PhysioGenix is Biotechnology in United States that focus on cardiovascular diseases business. Founded in 1997. They cover business area such as provider, preclinical pharmacology service, metabolic disorder, client drug development effort, pharmacodynamic (PD, pharmacokinetic (pk) study, relevant research model, its service, obesity, diabetes, cardiovascular disease.
1997
( 27 years old in 2024 )
Cardiovascular Diseases
-
1870 Westwood Drive
Westwood Drive
Brookfield, WI 53005
United States
Private
providerpreclinical pharmacology servicemetabolic disorderclient drug development effortpharmacodynamic (PDpharmacokinetic (pk) studyrelevant research modelits serviceobesitydiabetescardiovascular disease
* We use standard office opening hours in near PhysioGenix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
PhysioGenix is Biotechnology business from United States that founded in 1997 (27 years old in 2024), PhysioGenix business is focusing on Cardiovascular Diseases.
PhysioGenix headquarter office and corporate office address is located in 1870 Westwood Drive Westwood Drive Brookfield, WI 53005 United States.
PhysioGenix was founded in United States.
In 2024, PhysioGenix is currently focus on cardiovascular diseases sector.
Above is snippet of Google Trends for "cardiovascular diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with PhysioGenix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.